This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Algorae Pharmaceuticals Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Algorae Pharmaceuticals has a total shareholder equity of A$3.6M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$3.8M and A$140.2K respectively.

Belangrijke informatie

Verhouding schuld/eigen vermogen

AU$0

Schuld

Rente dekkingsratio	n/a
Contant	AU$3.62m
Aandelen	AU$3.62m
Totaal verplichtingen	AU$140.16k
Totaal activa	AU$3.76m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: LHI1's short term assets (A$3.8M) exceed its short term liabilities (A$140.2K).

Langlopende schulden: LHI1 has no long term liabilities.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: LHI1 is debt free.

Schuld verminderen: LHI1 has not had any debt for past 5 years.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: LHI1 has sufficient cash runway for more than a year based on its current free cash flow.

Voorspelling contante baan: LHI1 has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 10.4% each year.